Summit Therapeutics Inc.

Summit Therapeutics Inc. (SMMT)

FDA Applications

Note: This list only includes applications that have been responded to by the FDA.

ApplicationProduct NameActive IngredientFormStrengthStatus
NDA215487 - SUMMIT BIOSCI
REZENOPYNALOXONE HYDROCHLORIDESPRAY;NASAL10MG/SPRAYPrescription